(c) 2024 PillSync.com

irbesartan 150 MG Oral Tablet Avapro

INDICATIONS AND USAGE Hypertension AVAPRO (irbesartan) is indicated for the Treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. Nephropathy in Type 2 Diabetic Patients AVAPRO is indicated for the Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. In this population, AVAPRO reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end-stage renal disease (need for dialysis or renal transplantation) (see CLINICAL PHARMACOLOGY: Clinical Studies ).

Bristol-Myers Squibb Company


4 years ago OVAL WHITE logo 2772 irbesartan 150 MG Oral Tablet Avapro

OVAL WHITE logo 2772

4 years ago OVAL WHITE logo 2772 irbesartan 150 MG Oral Tablet Avapro

logo 2772 OVAL WHITE

HOW SUPPLIED AVAPRO ® (irbesartan) is available as white to off-white biconvex oval tablets, debossed with a heart shape on one side and a portion of the NDC code on the other. Unit-of-use bottles contain 30, 90, or 500 tablets and blister packs contain 100 tablets, as follows: 75 mg 150 mg 300 mg Debossing 2771 2772 2773 Bottle of 30 0087-2771-31 0087-2772-31 0087-2773-31 Bottle of 90 0087-2771-32 0087-2772-32 0087-2773-32 Bottle of 500 0087-2772-15 0087-2773-15 Blister of 100 0087-2772-35 Storage Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature].


More pills like OVAL logo 2772












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site